泰格医药
(300347)
| 流通市值：301.91亿 | | | 总市值：459.10亿 |
| 流通股本：5.66亿 | | | 总股本：8.61亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,505,267,395.07 | 2,055,344,830.04 | 1,967,632,936.81 | 3,172,620,470.07 |
| 应收票据及应收账款 | 1,160,831,579.74 | 1,365,768,881.61 | 1,244,919,487.1 | 1,346,556,781.14 |
| 其中：应收票据 | 5,442,740.11 | 6,010,700.41 | 3,674,560 | 13,644,901.84 |
| 应收账款 | 1,155,388,839.63 | 1,359,758,181.2 | 1,241,244,927.1 | 1,332,911,879.3 |
| 预付款项 | 127,897,613.99 | 101,932,971.27 | 119,048,268.73 | 86,532,181.89 |
| 其他应收款合计 | 89,069,273.51 | 89,030,886.84 | 102,962,088.09 | 105,960,575.94 |
| 其中:应收利息 | 323,542.46 | - | 16,771,156.69 | 17,376,536.37 |
| 存货 | 36,463,701.37 | 31,956,085.52 | 22,196,124.75 | 22,136,941 |
| 合同资产 | 2,744,926,377.29 | 2,504,689,617.5 | 2,940,514,164.81 | 2,811,792,918.88 |
| 其他流动资产 | 60,913,540.13 | 76,108,977.92 | 73,947,764.66 | 58,517,272.05 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,895,369,481.1 | 6,299,685,225.86 | 6,547,520,834.95 | 7,646,634,878.7 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,911,115,451.09 | 3,424,603,314.72 | 3,515,279,694.87 | 3,518,375,411.56 |
| 其他权益工具投资 | 7,742,987.79 | 8,090,146.65 | 10,629,739.38 | 9,872,440.95 |
| 其他非流动金融资产 | 10,127,018,013.77 | 10,105,905,487.26 | 10,716,445,742.86 | 10,497,204,889.49 |
| 固定资产 | 775,532,176.63 | 778,498,376.24 | 584,711,474.52 | 608,338,138.68 |
| 在建工程 | 442,678,469.38 | 420,535,374.37 | 516,620,831.31 | 472,627,690.59 |
| 使用权资产 | 451,265,271.46 | 487,230,305.93 | 509,187,439.2 | 456,868,986.13 |
| 无形资产 | 302,240,718.6 | 336,876,524.01 | 325,329,299.93 | 345,000,363.85 |
| 商誉 | 3,229,241,388.75 | 3,227,762,493.75 | 2,810,082,693.5 | 2,799,342,027.04 |
| 长期待摊费用 | 204,929,328.34 | 210,094,767.04 | 189,271,411.97 | 197,936,926.37 |
| 递延所得税资产 | 132,538,691.41 | 126,686,732.61 | 131,375,915.05 | 123,325,371.64 |
| 其他非流动资产 | 3,249,920,970.9 | 3,245,047,038.72 | 4,420,136,943.76 | 3,741,589,284.84 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 22,834,223,468.12 | 22,371,330,561.3 | 23,729,071,186.35 | 22,770,481,531.14 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 28,729,592,949.22 | 28,671,015,787.16 | 30,276,592,021.3 | 30,417,116,409.84 |
| 流动负债: | | | | |
| 短期借款 | 1,890,046,526.54 | 1,912,017,204.22 | 3,010,434,835 | 2,767,059,200 |
| 应付票据及应付账款 | 277,367,516.01 | 257,287,412.33 | 229,928,730.46 | 230,511,814.45 |
| 其中：应付票据 | 245,886.14 | - | 1,598,000 | 3,399,000 |
| 应付账款 | 277,121,629.87 | 257,287,412.33 | 228,330,730.46 | 227,112,814.45 |
| 合同负债 | 809,072,675.68 | 790,737,308.84 | 809,815,727.76 | 772,245,863.28 |
| 应付职工薪酬 | 246,830,641.32 | 243,974,190.43 | 165,533,781.62 | 233,446,905.33 |
| 应交税费 | 134,918,058.34 | 159,172,131.01 | 174,553,344.24 | 158,161,687.49 |
| 其他应付款合计 | 56,367,185.82 | 76,840,278.73 | 83,945,580.68 | 594,905,642.35 |
| 其中:应付利息 | 2,370,474.5 | 5,310,915.46 | 3,620,817.53 | 6,898,997.92 |
| 应付股利 | 2,122,452.46 | 2,609,775.37 | 1,823,888.87 | 513,481,650.41 |
| 一年内到期的非流动负债 | 196,482,147.17 | 198,600,777.18 | 299,686,178.53 | 555,727,450.13 |
| 其他流动负债 | 24,639,471.03 | 23,223,162.38 | 21,359,578.54 | 20,357,240.08 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,635,724,221.91 | 3,661,852,465.12 | 4,795,257,756.83 | 5,332,415,803.11 |
| 非流动负债: | | | | |
| 长期借款 | 581,674,789.07 | 323,649,635.25 | 397,237,083.72 | 404,817,974.35 |
| 租赁负债 | 383,138,008.77 | 399,316,716.16 | 444,120,824.43 | 386,754,553.73 |
| 长期应付职工薪酬 | 2,736,910.43 | 2,784,565.42 | 2,441,425.78 | 2,476,446.05 |
| 递延收益 | 17,107,868.94 | 17,136,295.72 | 14,111,379.63 | 14,462,985.38 |
| 递延所得税负债 | 200,601,111.6 | 201,796,922.9 | 204,624,399.71 | 208,712,497.33 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,185,258,688.81 | 944,684,135.45 | 1,062,535,113.27 | 1,017,224,456.84 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,820,982,910.72 | 4,606,536,600.57 | 5,857,792,870.1 | 6,349,640,259.95 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 864,948,570 | 864,948,570 | 864,948,570 | 864,948,570 |
| 资本公积 | 10,768,762,041.92 | 10,772,578,438.11 | 10,780,324,919.18 | 10,776,919,164.02 |
| 减:库存股 | 500,116,483.34 | 191,146,104.89 | 191,146,104.89 | 180,796,021.11 |
| 其他综合收益 | 105,034,982.43 | 99,095,699.24 | 77,377,043.56 | 91,214,186.82 |
| 盈余公积 | 436,529,393.76 | 436,529,393.76 | 436,529,393.76 | 436,529,393.76 |
| 未分配利润 | 8,854,116,194.93 | 8,688,647,453.5 | 9,096,932,877.14 | 8,776,352,812.65 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 20,529,274,699.7 | 20,670,653,449.72 | 21,064,966,698.75 | 20,765,168,106.14 |
| 少数股东权益 | 3,379,335,338.8 | 3,393,825,736.87 | 3,353,832,452.45 | 3,302,308,043.75 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 23,908,610,038.5 | 24,064,479,186.59 | 24,418,799,151.2 | 24,067,476,149.89 |
| 负债和股东权益合计 | 28,729,592,949.22 | 28,671,015,787.16 | 30,276,592,021.3 | 30,417,116,409.84 |
| 公告日期 | 2025-04-29 | 2025-03-28 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |